SE9601110D0 - Substituted 1,2,3,4-tetrahydronaphthalene derivatives - Google Patents

Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Info

Publication number
SE9601110D0
SE9601110D0 SE9601110A SE9601110A SE9601110D0 SE 9601110 D0 SE9601110 D0 SE 9601110D0 SE 9601110 A SE9601110 A SE 9601110A SE 9601110 A SE9601110 A SE 9601110A SE 9601110 D0 SE9601110 D0 SE 9601110D0
Authority
SE
Sweden
Prior art keywords
compounds
substituted
enantiomer
cycloalkyl
aryl
Prior art date
Application number
SE9601110A
Other languages
English (en)
Inventor
Stefan Berg
Lennart Florvall
Svante Ross
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601110A priority Critical patent/SE9601110D0/sv
Publication of SE9601110D0 publication Critical patent/SE9601110D0/sv
Priority to ZA9702056A priority patent/ZA972056B/xx
Priority to US08/836,004 priority patent/US6124283A/en
Priority to AT97914727T priority patent/ATE231847T1/de
Priority to DE69718771T priority patent/DE69718771T2/de
Priority to IL14568197A priority patent/IL145681A0/xx
Priority to JP9533410A priority patent/JP2000506883A/ja
Priority to CN97194726A priority patent/CN1073101C/zh
Priority to SK1188-98A priority patent/SK282359B6/sk
Priority to BR9708093A priority patent/BR9708093A/pt
Priority to HU9902454A priority patent/HUP9902454A3/hu
Priority to EP97914727A priority patent/EP0888319B1/en
Priority to NZ331613A priority patent/NZ331613A/xx
Priority to IL12607097A priority patent/IL126070A0/xx
Priority to TR1998/01868T priority patent/TR199801868T2/xx
Priority to PL97329121A priority patent/PL329121A1/xx
Priority to KR1019980707506A priority patent/KR20000064751A/ko
Priority to CA002247940A priority patent/CA2247940A1/en
Priority to CZ983019A priority patent/CZ301998A3/cs
Priority to AU21865/97A priority patent/AU709856B2/en
Priority to PCT/SE1997/000469 priority patent/WO1997034883A1/en
Priority to EE9800300A priority patent/EE9800300A/xx
Priority to HR9601110-1A priority patent/HRP970166A2/xx
Priority to IDP970931A priority patent/ID16298A/id
Priority to ARP970101163A priority patent/AR006360A1/es
Priority to ARP970105660A priority patent/AR010080A1/es
Priority to IS4844A priority patent/IS4844A/is
Priority to NO19984385A priority patent/NO311803B1/no
Priority to YU40998A priority patent/YU40998A/sh
Priority to US09/653,427 priority patent/US6410530B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
SE9601110A 1996-03-22 1996-03-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives SE9601110D0 (sv)

Priority Applications (30)

Application Number Priority Date Filing Date Title
SE9601110A SE9601110D0 (sv) 1996-03-22 1996-03-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ZA9702056A ZA972056B (en) 1996-03-22 1997-03-10 Substituted 1,2,3,4-tetrahydronaphthalene derivatives.
EE9800300A EE9800300A (et) 1996-03-22 1997-03-20 Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid
TR1998/01868T TR199801868T2 (xx) 1996-03-22 1997-03-20 1,2,3,4-tetrahidronaftalin t�revleri yerine e�de�erinin kullan�lmas�.
PL97329121A PL329121A1 (en) 1996-03-22 1997-03-20 Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
DE69718771T DE69718771T2 (de) 1996-03-22 1997-03-20 Substituierte 1,2,3,4-tetrahydronaphthalinderivate
IL14568197A IL145681A0 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
JP9533410A JP2000506883A (ja) 1996-03-22 1997-03-20 置換１，２，３，４―テトラヒドロナフタレン誘導体
CN97194726A CN1073101C (zh) 1996-03-22 1997-03-20 取代的1,2,3,4－四氢化萘衍生物
SK1188-98A SK282359B6 (sk) 1996-03-22 1997-03-20 Substituovaný 1,2,3,4-tetrahydronaftalénový derivát, farmaceutická formulácia s jeho obsahom, jeho použitie, spôsob jeho prípravy a medziprodukty na jeho prípravu
BR9708093A BR9708093A (pt) 1996-03-22 1997-03-20 Composto formulação uso composto e processo para tratamento de distúrbios mediados por 5-hidroxitriptamina e para preparação do composto
HU9902454A HUP9902454A3 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
EP97914727A EP0888319B1 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
NZ331613A NZ331613A (en) 1996-03-22 1997-03-20 Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives
IL12607097A IL126070A0 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
US08/836,004 US6124283A (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
AT97914727T ATE231847T1 (de) 1996-03-22 1997-03-20 Substituierte 1,2,3,4- tetrahydronaphthalinderivate
KR1019980707506A KR20000064751A (ko) 1996-03-22 1997-03-20 치환된1,2,3,4-테트라히드로나프탈렌유도체
CA002247940A CA2247940A1 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
CZ983019A CZ301998A3 (cs) 1996-03-22 1997-03-20 Substituované 1,2,3,4-tetrahydronaftalemové deriváty, jejich použití a způsob
AU21865/97A AU709856B2 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
PCT/SE1997/000469 WO1997034883A1 (en) 1996-03-22 1997-03-20 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
ARP970101163A AR006360A1 (es) 1996-03-22 1997-03-21 Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
HR9601110-1A HRP970166A2 (en) 1996-03-22 1997-03-21 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
IDP970931A ID16298A (id) 1996-03-22 1997-03-21 Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
ARP970105660A AR010080A1 (es) 1996-03-22 1997-12-02 Derivados de 1,2,3,4-tetrahidronaftaleno
IS4844A IS4844A (is) 1996-03-22 1998-09-09 Útskiptar 1,2,3,4-tetrahýdrónaftalenafleiður
NO19984385A NO311803B1 (no) 1996-03-22 1998-09-21 Substituerte 1,2,3,4-tetrahydronaftalenderivater, farmasöytisk preparat inneholdende slike derivater, deresanvendelse, fremgangsmåte for deres fremstilling, og mellomprodukt
YU40998A YU40998A (sh) 1996-03-22 1998-09-22 Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
US09/653,427 US6410530B1 (en) 1996-03-22 2000-08-31 Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601110A SE9601110D0 (sv) 1996-03-22 1996-03-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Publications (1)

Publication Number Publication Date
SE9601110D0 true SE9601110D0 (sv) 1996-03-22

Family

ID=20401907

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601110A SE9601110D0 (sv) 1996-03-22 1996-03-22 Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Country Status (27)

Country Link
US (2) US6124283A (sv)
EP (1) EP0888319B1 (sv)
JP (1) JP2000506883A (sv)
KR (1) KR20000064751A (sv)
CN (1) CN1073101C (sv)
AR (2) AR006360A1 (sv)
AT (1) ATE231847T1 (sv)
AU (1) AU709856B2 (sv)
BR (1) BR9708093A (sv)
CA (1) CA2247940A1 (sv)
CZ (1) CZ301998A3 (sv)
DE (1) DE69718771T2 (sv)
EE (1) EE9800300A (sv)
HR (1) HRP970166A2 (sv)
HU (1) HUP9902454A3 (sv)
ID (1) ID16298A (sv)
IL (2) IL126070A0 (sv)
IS (1) IS4844A (sv)
NO (1) NO311803B1 (sv)
NZ (1) NZ331613A (sv)
PL (1) PL329121A1 (sv)
SE (1) SE9601110D0 (sv)
SK (1) SK282359B6 (sv)
TR (1) TR199801868T2 (sv)
WO (1) WO1997034883A1 (sv)
YU (1) YU40998A (sv)
ZA (1) ZA972056B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
SE9703376D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703379D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
ATE273970T1 (de) 1998-04-16 2004-09-15 Pfizer Prod Inc N-acyl und n-aroyl aralkylamide
SE0002729D0 (sv) * 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
MXPA03006268A (es) 2001-01-16 2003-09-22 Astrazeneca Ab Compuestos terapeuticos de cromano.
NZ526697A (en) 2001-01-16 2005-05-27 Astrazeneca Ab Therapeutic heterocyclic compounds
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
SE0301798D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
DK1831159T3 (da) * 2004-12-21 2010-03-22 Hoffmann La Roche Tetralin og indanderivater samt anvendelser deraf
JP2009533325A (ja) * 2006-03-17 2009-09-17 アストラゼネカ・アクチエボラーグ ５−ｈｔ６調節剤としての新規なテトラリン
WO2008130321A2 (en) * 2007-04-23 2008-10-30 Astrazeneca Ab Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
SA08290245B1 (ar) 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
WO2008130323A1 (en) * 2007-04-23 2008-10-30 Astrazeneca Ab Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
WO2008130322A1 (en) * 2007-04-23 2008-10-30 Astrazeneca Ab Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
WO2008130319A2 (en) * 2007-04-23 2008-10-30 Astrazeneca Ab Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP6888827B2 (ja) * 2015-05-19 2021-06-16 ノースイースタン ユニバーシティ 末梢におけるセロトニン受容体をモジュレートするための化合物または方法
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919624A1 (de) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE197145T1 (de) * 1991-02-08 2000-11-15 Lilly Co Eli Ringsubstituierte 2-amino-1,2,3,4- tetrahydronaphtahline und 3-aminochromane
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
GB2273930A (en) * 1992-12-30 1994-07-06 Glaxo Group Ltd Benzanilide derivatives
DK0689536T3 (da) * 1993-03-16 2001-07-30 Pfizer Naphthalenderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
JPH09503773A (ja) * 1993-10-19 1997-04-15 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ−１ｄレセプター拮抗剤用のベンズアニリド誘導体
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703376D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination

Also Published As

Publication number Publication date
AR010080A1 (es) 2000-05-17
IL126070A0 (en) 1999-05-09
US6410530B1 (en) 2002-06-25
YU40998A (sh) 1999-09-27
TR199801868T2 (xx) 1998-12-21
DE69718771T2 (de) 2003-10-23
NZ331613A (en) 2000-03-27
US6124283A (en) 2000-09-26
CN1219170A (zh) 1999-06-09
BR9708093A (pt) 1999-07-27
JP2000506883A (ja) 2000-06-06
EP0888319B1 (en) 2003-01-29
AR006360A1 (es) 1999-08-25
AU2186597A (en) 1997-10-10
KR20000064751A (ko) 2000-11-06
SK282359B6 (sk) 2002-01-07
HRP970166A2 (en) 1998-04-30
WO1997034883A1 (en) 1997-09-25
SK118898A3 (en) 1999-03-12
PL329121A1 (en) 1999-03-15
CZ301998A3 (cs) 1999-05-12
CN1073101C (zh) 2001-10-17
HUP9902454A3 (en) 2002-01-28
NO311803B1 (no) 2002-01-28
ATE231847T1 (de) 2003-02-15
AU709856B2 (en) 1999-09-09
IL145681A0 (en) 2002-06-30
CA2247940A1 (en) 1997-09-25
ID16298A (id) 1997-09-18
NO984385L (no) 1998-11-23
NO984385D0 (no) 1998-09-21
ZA972056B (en) 1997-09-22
IS4844A (is) 1998-09-09
EE9800300A (et) 1999-02-15
DE69718771D1 (de) 2003-03-06
HUP9902454A2 (hu) 1999-11-29
EP0888319A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
SE9601110D0 (sv) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9702799D0 (sv) New compounds
HUP0401086A2 (hu) 4-[(Fenil-piperazinil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, szorongás vagy gasztrointesztinális zavarok kezelésére szolgáló gyógyszerkészítmények előállítására és eljárás a vegyületek előállítására
TW345575B (en) Pharmaceutical composition comprising an inhibitor for ras farnesylation and the preparation of the inhibitor compound
PT100620A (pt) Derivados de tetra-hidrocarbazol, seu uso e preparacao e composicoes farmaceuticas que os contem
SE0104332D0 (sv) Therapeutic agents
SE9703377D0 (sv) New compounds
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
BR9812239A (pt) Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
HUP0401883A2 (hu) Muszkarin agonisták és ezeket tartalmazó gyógyászati készítmények
JO1617B1 (en) Modern 2-amino-tetraline-8 compounds
HUP0001093A2 (hu) 5-HT2A-antagonista oxazolidinon-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
FI933719A0 (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
NO913023L (no) Nye bicykliske aminosubstituerte forbindelser
HUP0201863A2 (hu) Új morfolinszármazékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
ES2021261A6 (es) Procedimiento de preparacion de nuevos derivados aminopropanoles racemicos u opticamente activos, sus sales de adicion acida y sus derivados amonicos cuaternarios.
NO913543D0 (no) Fremgangsmaate for fremstilling av 3-(1h-indazol-3-yl)-4-pyridinaminer og mellomprodukter, og anvendelse som medikamenter.
HUP0003856A2 (hu) 6-Pirrolidin-2-ilpirindin-származékok, eljárás előállításukra és gyógyászati alkalmazásuk
NO20020475L (no) 2-aminotetralinderivater for terapi av glaukom
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
HUP9901139A2 (hu) Melatonin agonisták alkalmazása jóindulatú prosztata hiperplázia kezelésére alkalmas gyógyászati készítmények előállítására
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.
HUP0202237A2 (hu) Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk